Lv2
190 积分 2022-09-02 加入
A phase Ib/II study of cadonilimab (PD-1/CTLA-4 bispecific antibody) plus anlotinib as first-line treatment in patients with advanced non-small cell lung cancer
1天前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
23天前
已完结
Cardiovascular toxicities of immune therapies for cancer – a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio‐Oncology
3个月前
已完结
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
6个月前
已完结
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
7个月前
已完结
[Expert consensus on diagnosis and treatment of malignant pleural effusion caused by lung cancer]
8个月前
已完结
[Chinese expert consensus on clinical testing standards of PD-L1 expression for non-small cell lung cancer (2023 version)]
8个月前
已完结
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study
9个月前
已完结
Interstitial Lung Disease
11个月前
已完结
Interstitial lung diseases
11个月前
已完结
Silver nanoparticles/carbon dots nanocomposite with potent antibiofilm and long-term antimicrobial activity doped into chitosan/polyvinyl alcohol film for food preservation
11个月前
已采纳
The polysaccharide from purple sweet potato (Ipomoea batatas (L.) Lam) alleviates lipopolysaccharide-induced acute lung injury in mice via the VIP/cAMP/PKA/AQPs signaling pathway
11个月前
已采纳
Fish skin dressing for wound regeneration: A bioactive component review of omega-3 PUFAs, collagen and ECM
11个月前
已采纳
Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis
11个月前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer
1年前
已采纳
皖公网安备34019202002308
